BioXcel Therapeutics BTAI
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 2.56 | -2.18 | -14,228 | -31 | ||
| 2025Q2 | 1.81 | -2.45 | -15,852 | -19 | ||
| 2025Q1 | 2.03 | 309.69 | -1.50 | -10,099 | -7 | |
| 2024Q4 | 5.98 | 153.70 | -2.87 | -10,493 | -11 | |
| 2024Q3 | 9.76 | 155.10 | -4.80 | -15,293 | -14 | |
| 2024Q2 | 20.48 | 376.08 | -1.95 | -17,296 | -8 | |
| 2024Q1 | 45.12 | 104.22 | -13.89 | -24,163 | -27 | |
| 2023Q4 | 47.20 | 105.60 | -11.93 | -19,875 | -22 | |
| 2023Q3 | 40.48 | 102.25 | -27.52 | -48,296 | -50 | |
| 2023Q2 | 106.56 | 104.29 | -29.44 | -52,413 | -54 | |
| 2023Q1 | 298.56 | 103.58 | -29.44 | -51,198 | -53 | |
| 2022Q4 | 343.68 | 101.94 | -31.36 | -52,894 | -55 | |
| 2022Q3 | 189.12 | 99.58 | -23.84 | -38,983 | -42 | |
| 2022Q2 | 211.20 | 100.57 | -21.60 | -36,288 | -38 | |
| 2022Q1 | 334.56 | 100.05 | -17.92 | -31,480 | -31 | |
| 2021Q4 | 325.28 | 100.17 | -14.72 | -26,131 | -26 | |
| 2021Q3 | 485.60 | 100.04 | -15.20 | -26,812 | -27 | |
| 2021Q2 | 464.96 | 100.04 | -17.60 | -27,613 | -28 | |
| 2021Q1 | 690.56 | 100.04 | -17.28 | -26,379 | -26 | |
| 2020Q4 | 739.20 | 100.07 | -13.60 | -21,097 | -21 |